SA-FORD

Mumbai, India Founded: 2008 • Age: 18 yrs
Provides chemistry, toxicology testing, and regulatory studies for clients.

About SA-FORD

SA-FORD is a Healthcare company based in Mumbai (India) founded in 2008. It provides chemistry, toxicology testing, and regulatory studies for clients. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 257 employees. Its Indian entity Sharon Bio-Medicine Limited reported revenue of β‚Ή204 Cr. SA-FORD offers products and services including Analytical Testing, Impurity Profiling, and Reproductive and Developmental Testing. Its focus areas include Biotech, Toxicology, Regulatory Studies and Chemicals.

Company details

Sa-Ford specializes in chemistry, mutagenicity, and toxicological studies conducted in vivo and in vitro. They provide services like analytical testing, physico-chemical testing, and impurity profiling while adhering to guidelines such as OECD and ECHA. Operating from facilities in India and Europe, they serve clients in non-clinical regulatory research, ensuring quality and compliance. Their focus includes building global relationships through reliable services.

  • Headquarters Mumbai, India
  • Employees 257
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website sa-ford.com
  • Social LinkedIn Facebook
  • Legal Name Sharon Bio-Medicine Limited
  • Date of Incorporation 19 Jun, 1989
  • Jurisdiction Panvel, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹204 Cr

    FY 2025 · -20% YoY

  • Net Profit
    ₹23.18 Cr

    FY 2025 · 11% margin

  • EBITDA
    ₹51.37 Cr

    FY 2025 · 25% margin

  • Employee Count
    257

Products & Services of SA-FORD

SA-FORD offers a comprehensive portfolio of products and services, including Analytical Testing, Impurity Profiling, and Reproductive and Developmental Testing.

Analytical Testing
Testing Services

Conducts physico-chemical and impurity tests for regulatory compliance.

Impurity Profiling
Chemical Analysis

Analyzes impurities in substances for safety and quality assurance.

Reproductive and Developmental Testing
Toxicology Services

Performs studies on reproductive effects in compliance with guidelines.

Board of directors of Sharon Bio-Medicine Limited (SA-FORD)

Sharon Bio-Medicine Limited is the primary company behind SA-FORD. The board of Sharon Bio-Medicine Limited currently have 4 directors; the longest-serving is Purushottam Sharma, appointed in 2023. 21 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Purushottam Sharma
DIN 08699409
Director17 Jun 20233 yrs 5 moSharon Bio-Medicine Limited
Mukeshkumar Siyaram Singh
DIN 10186380
Whole-time director17 Jun 20233 yrs 5 moSharon Bio-Medicine Limited
Jayant Vasudeo Rao
DIN 03627850
Director17 Jun 20233 yrs 5 moSharon Bio-Medicine Limited
Mahendar Korthiwada
DIN 09558992
Director29 Nov 20232 yrs 11 moSharon Bio-Medicine Limited

Financials of SA-FORD

Figures of Sharon Bio-Medicine Limited, the primary company behind SA-FORD, for FY 2025. Revenue was ₹204 Cr (-20% year on year). Net profit was ₹23.18 Cr (11% margin). EBITDA was ₹51.37 Cr (25% margin). Revenue has grown at a compounded annual rate of +2% over three years.

  • ₹204 CrRevenue · FY 2025 · -20% YoY
  • ₹23.18 CrNet profit · 11% margin
  • ₹51.37 CrEBITDA · 25% margin
  • ₹47,952Paid-up capital
  • 258Employees (provident fund records)
  • +2%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Sharon Bio-Medicine Limited are on its company page.

Premium access

Detailed financial statements for SA-FORD

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sa-Ford

Premium access

Complete news archive for SA-FORD

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SA-FORD

SA-FORD was founded in 2008.

SA-FORD is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

SA-FORD has 257 employees.

The primary company behind SA-FORD, Sharon Bio-Medicine Limited, reported revenue of β‚Ή204 Cr for FY 2025, down 20% year on year.

Sa-Ford specializes in chemistry, mutagenicity, and toxicological studies conducted in vivo and in vitro. They provide services like analytical testing, physico-chemical testing, and impurity profiling while adhering to guidelines such as OECD and ECHA. Operating from facilities in India and Europe, they serve clients in non-clinical regulatory research, ensuring quality and compliance. Their focus includes building global relationships through reliable services.

SA-FORD offers Analytical Testing, Impurity Profiling, and Reproductive and Developmental Testing.

SA-FORD operates through Sharon Bio-Medicine Limited.

The legal entities of SA-FORD currently have 7 directors, including Purushottam Sharma, Mukeshkumar Siyaram Singh, Mahendar Korthiwada and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available